Revance Therapeutics Inc (RVNC)
Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL Relational Commerce Platform and HintMD platform.
RVNC SEC Filing Email Alerts Service
Company Name: |
Revance Therapeutics Inc |
Website: |
www.revance.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding RVNC: |
22 |
Total Market Value Held by ETFs: |
$31.66M |
Total Market Capitalization: |
$336.00M |
% of Market Cap. Held by ETFs: |
9.42% |
|
|
April 19, 2024 10:02 AM Eastern
Buy (3.18 out of 4)
100th percentile
|
|